Abstract
The effect of ascorbic acid on the availability of propranolol has been examined. After oral administration of propranolol 80 mg with or without ascorbic acid pretreatment (2 g), the plasma concentrations and urinary excretion of propranolol and its metabolites, 4-hydroxy-propranolol and propranolol-conjugated, were determined by HPLC. Compared to controls, vitamin C decreased the maximum concentration of propranolol from 463 to 334 nmol·l−1, and the area under the propranolol concentration-time curve (from 0 to 24 hours) from 3,13 to 1,96 μmol·l−1·h. The time to reach maximum propranolol concentration was increased from 1,9 to 2,7. The total amount of drug recovered in urine has also significantly diminished (from 12,6 to 4,29 mg). No change in elimination rate was observed, indicating that ascorbic acid had affected both the absorption process and the first pass metabolism. The heart-rate decreased less when propranolol was administered with ascorbic acid in comparison to control subjects, although this interaction has little biological importance.
Similar content being viewed by others
References
Routledge PA, Shand DG (1979) Clinical pharmacokinetics of propranolol. Clin Pharmacokinet 4:73–90
Kornhauser DM, Wood AJJ, Vestal RE, Wilkinson GR, Branch RA, Shand DG (1978) Biological determinants of propranolol disposition in man. Clin Pharmacol Ther 23:165–174
Pacifici GM, Giuliani L, Calcaprina R (1986) Glucuronidation of 1-Naphtol in nuclear and microsomal fractions of the human intestine. Pharmacology 33:1203–1109
Pacifici GM, Eligi M, Giuliani L (1993) (+) and (−) terbutaline are sulphated at the higher rate in human intestine than in the liver. Eur J Clin Pharmacol 45:483–487
Olanoff LS, Walle T, Douglas T, Walle UK, Oexmann MJ, Conradi EC (1986) Food effect on propranolol systemic and oral clearance: Support for a blood flow hypothesis. Clin Pharmacol Ther 40:408–414
Welling PG (1984) Interactions affecting drug absorption. Clin Pharmacokinet 9:404–34
Liedholm H, Melander A (1986) Concomitant food intake can increase the bioavailability of propranolol by transient inhibition of its presystemic primary conjugation. Clin Pharmacol Ther 40:29–36
Pantuck EJ, Pantuck CB, Kappas A, Coney AH, Anderson KE (1991) Effects of protein and carbohydrate content of diet on drug conjugation. Clin Pharmacol Ther 50:254–258
Fagan TC, Walle T, Oexmann MJ, Walle UK, Bai SA, Gaffney TE (1987) Increased clearance of propranolol and theophylline by high-protein compared with high-carbohydrate diet. Clin Pharmacol Ther 41:402–406
Merkel U, Sigusch H, Hoffman A (1994) Grapefruit juice inhibits 7-hydroxylation of coumarin in healthy volunteers. Eur J Clin Pharmacol 46:175–177
Bailey DG, Malcolm JO, Arnold H, Strong A, Muñoz C, Spence JD (1993) Effect of grapefruit and naringin on nisoldipine pharmacokinetics. Clin Pharmacol Ther 54:589–594
Rogers SM, Back DJ, Orme ML'E (1987) Intestinal metabolism of ethinylestradiol and paracetamol in vitro: studies using Ussing Chambers Br J Clin Pharmacol 23:727–734
Rogers SM, Back DJ, Stevenson PJ, Grimmer SFM, Orme ML'E (1987) Paracetamol interaction with oral contraceptive steroids: increased plasma concentrations of ethinylestradiol. Br J Clin Pharmacol 23:721–725
Back DJ, Orme ML'E (1990) Pharmacokinetic drug interactions with oral contraceptives. Clin Pharmacokinet 18:472–484
Varin F, Cubbedu LX, Powell JR (1986) Liquid chromatographic assay and disposition of carvedilol in healthy volunteers. J Pharm Sci 75:1195–1197
Don Brown R, Manno JE (1978) STRIP, a basic computer program for obtaining initial polyexponential parameter estimates. J Pharm Sci 67:1687–1691
Matsuki Y, Katakuse Y, Matsuura H, Kiwada H, Goromatu T (1991) Effects of glucose and ascorbic acid on absorption and first pass metabolism of isoniazid in rats. Chem Pharm Bull 39:445–448
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Gonzalez, J.P., Calvo, R., Rodríguez-Sasiaín, J.M. et al. Influence of vitamin C on the absorption and first pass metabolism of propranolol. Eur J Clin Pharmacol 48, 295–297 (1995). https://doi.org/10.1007/BF00198315
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00198315